Synapse - Works

Results (116513)

Clinical outcomes and cost of outpatient community-based treatment for rituximab refractory non-Hodgkins Lymphoma (NHL) patients

Meeting Abstract

Zelenetz, A. D.; Tang, B. X.; Frame, D.; Nalysnyk, L.; Cella, C.; Noel, J. K.
Blood (2004)

Fulltext@MSK | Save

Correlation of long-term biochemical outcome with post-treatment biopsy results for patients treated with 3-dimensional conformal radiotherapy for prostate cancer

Meeting Abstract

Zelefsky, M. J.; Chan, H. M.; Fuks, Z.; Reuter, V.; Leibel, S. A.
International Journal of Radiation Oncology, Biology, Physics (2004)

Fulltext@MSK | Save

Comparison of 5-year outcomes between conformal LDR brachytherapy and high dose IMRT for patients with clinically localized prostate cancer

Meeting Abstract

Zelefsky, M.; Yamada, J.; Fuks, Z.; Chan, H.; Cohen, G.; Zaider, M.; Leibel, S.
Radiotherapy and Oncology (2004)

Fulltext@MSK | Save

Dose volume considerations for urethral, rectal and erectile function for patients treated with permanent interstitial implantation

Meeting Abstract

Zelefsky, M.
Radiotherapy and Oncology (2004)

Fulltext@MSK | Save

Sputum analysis in lung cancer

Meeting Abstract

Zakowski, M. F.
Lung Cancer (2004)

Fulltext@MSK | Save

Defining low/high dose rate as if biology mattered

Meeting Abstract

Zaider, M.
Radiotherapy and Oncology (2004)

Fulltext@MSK | Save

Autoreactive B cells and immune tolerance alterations in peripheral blood of patients with systemic autoimmunity

Meeting Abstract

Yurasov, S. V.; Wardemann, H.; Hammersen, J.; Pascual, V.; Meffre, E.; Nussenzweig, M. C.
Pediatric Research (2004)

Fulltext@MSK | Save

Langerhans cells modified by gene transfer of full length CMV pp65 are more potent inducers of cytolytic T lymphocytes in a CD4-dependent manner than either CMV p495 gene-modified or p495 peptide-pulsed Langerhans cells

Meeting Abstract

Yuan, J.; Latouche, J. B.; Hodges, J.; Heller, G.; Riviere, I.; Sadelain, M.; Young, J. W.
Molecular Therapy (2004)

Fulltext@MSK | Save

Correlation of dosimetric factors and radiation pneumonitis incidence for non-small-cell lung cancer (NSCLC) patients in a recently completed dose escalation study

Meeting Abstract

Yorke, E. D.; Jackson, A.; Rosenzweig, K. E.; Braban, L.; Leibel, S. A.; Ling, C. C.
International Journal of Radiation Oncology, Biology, Physics (2004)

Fulltext@MSK | Save

Comparison of two inverse IMRT treatment planning systems

Meeting Abstract

Yenice, K.; Chang, J.; Hong, L.; Braban, L.; Hunt, M.; Chui, C.; Amols, H.
Medical Physics (2004)

Fulltext@MSK | Save